Life Technologies Corp. v. Promega Corp., 580 U.S. ___ (2017), was a case in which the United States Supreme Court clarified the application of the Patent Act of 1952 to the sale of components of patented inventions in foreign markets.

[1] In an opinion written by Associate Justice Sonia Sotomayor, the Court held that the sale of a "single component" in a foreign market "does not constitute a substantial portion of the components that can give rise to liability under [the Patent Act of 1952].

"[2] Justice Samuel Alito wrote an opinion concurring in part and concurring in the judgment, in which he was joined Justice Clarence Thomas.

[3] Chief Justice John Roberts took no part in the decision of the case.

This article related to the Supreme Court of the United States is a stub.